Skip to content
OpenCapital
Get started

Mesa Laboratories MLAB Q3 2026 earnings

Reported February 3, 2026 · Before market open

Revenue$65.1MBeat by $1.9MDiluted EPS$3.07Beat by $1.67
Revenue estimate$63.2M
EPS estimate$1.40

Next report

Aug 10, 2026 (In 4 weeks)
Revenue estimate$60.9M
EPS estimate$2.63

Financials

Q3 2026

Income statement

See full
Revenue$65.1M+3.6%
Net income$3.6M+317%

Balance sheet

See full
Cash & equivalents$29.0M+6.1%
Total debt$66.6M-60.3%
Total equity$186.7M+20.3%
Total assets$434.8M+0.3%

Cash flow

See full
Operating cash flow$18.8M+3.4%
CapEx$732.0K-10.0%
Free cash flow$18.0M+4.1%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$433.5M-39.5%
Enterprise value$471.14M-45.0%
P/E116.1×—
P/S1.8×-1.3×

Profitability

See full
Net margin1.5%+0.8pp
FCF margin15.3%-2.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.7×
Current ratio1.9×+1.3×

Segments

By geography

See full
US$29.9M-1.9%
Other$29.6M+13.6%
CN$5.6M-10.7%

By segment

See full
Biopharmaceutical Development$14.4M—
Clinical Genomics$11.8M—

By product

See full
Consumables$36.7M—
Hardware And Software$17.3M—

Versus estimates

Revenue

Q4 2026$63.7MMiss by $1.5M
Q3 2026$65.1MBeat by $1.9M
Q2 2026$60.7MMiss by $296.3KQ1 2026$59.5MMiss by $857.0KQ4 2025$62.1MBeat by $235.0KQ3 2025$62.8MBeat by $1.3M

Diluted EPS

Q4 2026$2.76Beat by $0.67
Q3 2026$3.07Beat by $1.67
Q2 2026$1.76Beat by $0.20Q1 2026$2.32Miss by $0.14Q4 2025$2.23Miss by $0.52Q3 2025$2.67Beat by $1.26

Ask the moment Mesa Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Mesa Laboratories report Q3 2026 earnings?
Mesa Laboratories (MLAB) reported Q3 2026 earnings on February 3, 2026 before market open.
What were Mesa Laboratories's Q3 2026 revenue and EPS?
Mesa Laboratories reported revenue of $65.1M and diluted EPS of $3.07 for Q3 2026.
Did Mesa Laboratories beat estimates in Q3 2026?
Revenue beat the consensus estimate of $63.2M by $1.9M. EPS beat the consensus estimate of $1.40 by $1.67.
How did Mesa Laboratories's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.6% from $62.8M a year earlier and diluted EPS grew 15.0% from $2.67.
Where can I find Mesa Laboratories's Q3 2026 SEC filings?
You can read the 8-K earnings release (0000724004-26-000015) and the 10-Q periodic report (0000724004-26-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.